March 11-14, 2024 | Part of BPI West
Town and Country Resort,
San Diego, CA
CAR, T, AND EMERGING CELL LINES: IMPROVE THE SAFETY, EFFICACY & REACH OF YOUR NOVEL CAR MODALITIES THROUGH TRANSLATIONAL SCIENCE AND CUTTING EDGE CLINICAL DATA
Revolutionizing cell and gene engineering - ground breaking autologous, allogeneic and in vivo treatments for blood borne and solid tumors
Thank You to the 1000+ Attendees at Next Generation CAR & T Cell Therapies and BPI US West 2023!
This year was the largest BPI US West / Next Generation CAR & T Cell Therapies Event in history, gathering 1000+ in-person attendees working across all phases of biopharmaceutical development and production. The presentation recordings will be available for conference attendees to watch in the ConnectMe platform starting on March 7 for a two week period. After the 2 week period concludes, the presentations will be available on our Streamly video platform for 12 months.
Mark your calendar to join us at next year's event, held March 11-14, 2024 as we return to San Diego! Sign up for email updates below and check out our full calendar of upcoming events at www.BioProcessEvents.com
Get the Latest Event Updates
NEXT GENERATION CAR & T CELL THERAPIES AND BPI US WEST 2023 BY THE NUMBERS
1000+
Global Scientists, Executives and Technology Leaders Working Across All Phases of Bioprocessing
90+
Exhibitors Devoted to Accelerating Your Product Through the Pipeline to Market
125+
Scientific Case Studies and New Data Presentations Across 6 Focused Tracks
2023 Speakers: The brightest minds in immuno-oncology & T cell therapies
Novel Technological Advances & Applications to help you Revolutionize Early Phase Development
Below are the key topics to be covered during this years event.
Emerging CGT 2.0 Cell Lines
The exploration of novel cell lines to be used in CAR-based therapies has opened many possibilities for future ‘CGT 2.0’ treatments, both allogeneic and autologous.
Join us at our new CAR & T Cell Therapies track within BPI West to learn more about these emerging CGT 2.0 cell lines, and the opportunities they hold.
Overcome Solid Tumour Obstacles and Improve Efficacy
Novel developments in how to approach solid tumour treatment with CAR-T and cutting-edge cell modalities are improving treatment outcomes.
Learn more about overcoming solid tumour obstacles by hearing from experts about their approaches to improve the efficacy of your developing therapies.
New Horizons with in vivo and Post CAR Approaches
From current issues to upcoming potentials, the future of the field is vast. New receptor modalities hope to solve the shortcomings of CAR, and an In Vivo approach may revolutionise CGT administration.
Attend Next Generation CAR & T Cell Therapies 2023 to learn about the findings from experts in this ever-evolving space.
CONNECT WITH KEY BUYERS AT NEXT GENERATION CAR & T CELL THERAPIES 2023
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 (0)7717 508900